| Dr Wendy Conger, MD | |
|
601 W 2nd St, Bloomington, IN 47403-2317 | |
| (812) 353-6821 | |
| Not Available |
| Full Name | Dr Wendy Conger |
|---|---|
| Gender | Female |
| Speciality | Emergency Medicine |
| Experience | 28 Years |
| Location | 601 W 2nd St, Bloomington, Indiana |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1487681334 | NPI | - | NPPES |
| 200233710 | Medicaid | IN | |
| 01050379B | Other | IN | CSR |
| 01050379A | Other | IN | INDIANA LICENSE |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207P00000X | Emergency Medicine | 01050379A (Indiana) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Columbus Regional Hospital | Columbus, IN | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Emergency Physicians Inc Of Columbus | 1557265287 | 8 |
News Archive
A new American study presented today at EULAR 2012, the Annual Congress of the European League Against Rheumatism, calls for more aggressive management of osteoporosis in the extreme elderly as the true impact of osteoporotic hip fractures in those aged 80 years or older is unveiled.
Investigators at Burnham Institute for Medical Research (Burnham) and the University of Connecticut Health Center (U.C.H.C.) have gained new understanding of the role hyaluronic acid (HA) plays in skeletal growth, chondrocyte maturation and joint formation in developing limbs.
Scientists are reporting a discovery of the potential basis for a urine test to diagnose community-acquired pneumonia (CAP), a difficult-to-diagnose disease that is the sixth leading cause of death in the United States.
Scientists have devised a method for coaxing mouse embryonic stem cells into forming a highly specific motor neuron subtype. The research, published by Cell Press in the September 3rd issue of the journal Cell Stem Cell, provides new insight into motor neuron differentiation and may prove useful for devising and testing future therapies for motor neuron diseases.
Enobia Pharma today announced positive results for its Phase II juvenile clinical trial of ENB-0040 (asfotase alfa), an experimental bone-targeted enzyme replacement therapy intended for the treatment of hypophosphatasia (HPP). Hypophosphatasia is a rare, inherited, and sometimes fatal metabolic bone disease that affects individuals of all ages.
› Verified 7 days ago
| Entity Name | Emergency Physicians Inc Of Columbus |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1912951062 PECOS PAC ID: 1557265287 Enrollment ID: O20031124000395 |
News Archive
A new American study presented today at EULAR 2012, the Annual Congress of the European League Against Rheumatism, calls for more aggressive management of osteoporosis in the extreme elderly as the true impact of osteoporotic hip fractures in those aged 80 years or older is unveiled.
Investigators at Burnham Institute for Medical Research (Burnham) and the University of Connecticut Health Center (U.C.H.C.) have gained new understanding of the role hyaluronic acid (HA) plays in skeletal growth, chondrocyte maturation and joint formation in developing limbs.
Scientists are reporting a discovery of the potential basis for a urine test to diagnose community-acquired pneumonia (CAP), a difficult-to-diagnose disease that is the sixth leading cause of death in the United States.
Scientists have devised a method for coaxing mouse embryonic stem cells into forming a highly specific motor neuron subtype. The research, published by Cell Press in the September 3rd issue of the journal Cell Stem Cell, provides new insight into motor neuron differentiation and may prove useful for devising and testing future therapies for motor neuron diseases.
Enobia Pharma today announced positive results for its Phase II juvenile clinical trial of ENB-0040 (asfotase alfa), an experimental bone-targeted enzyme replacement therapy intended for the treatment of hypophosphatasia (HPP). Hypophosphatasia is a rare, inherited, and sometimes fatal metabolic bone disease that affects individuals of all ages.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Wendy Conger, MD Po Box 4777, Bloomington, IN 47402-4777 Ph: (812) 336-1690 | Dr Wendy Conger, MD 601 W 2nd St, Bloomington, IN 47403-2317 Ph: (812) 353-6821 |
News Archive
A new American study presented today at EULAR 2012, the Annual Congress of the European League Against Rheumatism, calls for more aggressive management of osteoporosis in the extreme elderly as the true impact of osteoporotic hip fractures in those aged 80 years or older is unveiled.
Investigators at Burnham Institute for Medical Research (Burnham) and the University of Connecticut Health Center (U.C.H.C.) have gained new understanding of the role hyaluronic acid (HA) plays in skeletal growth, chondrocyte maturation and joint formation in developing limbs.
Scientists are reporting a discovery of the potential basis for a urine test to diagnose community-acquired pneumonia (CAP), a difficult-to-diagnose disease that is the sixth leading cause of death in the United States.
Scientists have devised a method for coaxing mouse embryonic stem cells into forming a highly specific motor neuron subtype. The research, published by Cell Press in the September 3rd issue of the journal Cell Stem Cell, provides new insight into motor neuron differentiation and may prove useful for devising and testing future therapies for motor neuron diseases.
Enobia Pharma today announced positive results for its Phase II juvenile clinical trial of ENB-0040 (asfotase alfa), an experimental bone-targeted enzyme replacement therapy intended for the treatment of hypophosphatasia (HPP). Hypophosphatasia is a rare, inherited, and sometimes fatal metabolic bone disease that affects individuals of all ages.
› Verified 7 days ago
Ronald C Jenson, DO Emergency Medicine Medicare: Not Enrolled in Medicare Practice Location: 4794 Red Oak Ln, Bloomington, IN 47401 Phone: 812-396-9620 | |
Dr. Robert Stone, MD Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 514 W 2nd St, Bloomington, IN 47403 Phone: 812-353-3719 Fax: 812-353-3713 | |
Dr. Christina M Cabott, DO Emergency Medicine Medicare: Medicare Enrolled Practice Location: 601 W 2nd St, Bloomington, IN 47403 Phone: 812-336-1690 Fax: 812-349-1325 | |
Dr. John Austin Lee, MD, MPH Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 2651 E Discovery Pkwy, Bloomington, IN 47408 Phone: 812-353-9515 Fax: 812-353-9275 | |
Dr. Carlyle George Langhorn Jr., M.D. Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 2651 E Discovery Pkwy, Bloomington, IN 47408 Phone: 812-353-9515 | |
Jonathan D Hart, M.D. Emergency Medicine Medicare: Not Enrolled in Medicare Practice Location: 2605 E Creeks Edge Dr, Bloomington, IN 47401 Phone: 812-355-2300 Fax: 812-355-2316 | |
Mary Smith, MD Emergency Medicine Medicare: Not Enrolled in Medicare Practice Location: 601 W 2nd St, Bloomington, IN 47403 Phone: 812-353-9515 Fax: 812-353-9275 |